1 |
Storrer KM,Müller CS,Pessoa MCA,et al.Connective tissue disease-associated interstitial lung disease [J].J Brasileiro de Pneumolog,2024,50(1):e20230132.
|
2 |
黄 慧.间质性肺疾病年度进展2023[J].中华结核和呼吸杂志,2024,47(1):44-49.
|
3 |
董学峰,常 乐,蔡振煜.血清ESR、CRP 及PLR、MLR 联合诊断结缔组织相关性间质性肺炎的意义[J/CD].中华肺部疾病杂志(电子版),2024,17(3):430-433.
|
4 |
梁 洁,陈玉兰,卢睿凌,等.结缔组织病相关间质性肺病血清生物标志物的研究进展[J].中华内科杂志,2024,63(3):310-315.
|
5 |
Bravo GÁ,Cedeño RR,Casadevall MP,et al.Sphingosine-1-phosphate(S1P) and S1P signaling pathway modulators,from current insights to future perspectives[J].Cells,2022,11(13):2058-2071.
|
6 |
蒋 艳,张韶泽,曾 丹,等.1-磷酸鞘氨醇在呼吸系统疾病中的研究进展[J].中国医师杂志,2021,23(12):1909-1913.
|
7 |
Hutami IR.The roles of sphingosine-1-phosphate (S1p) on arthritis[J].Odonto:Dental J,2024,11(1):115-123.
|
8 |
Li J,Huang Y,Zhang Y,et al.S1P/S1PR signaling pathway advancements in autoimmune diseases[J].Biomol Biomed,2023,23(6):922-935.
|
9 |
Tanaka T,Koyama K,Takahashi N,et al.Lysophosphatidic acid,ceramide 1-phosphate and sphingosine 1-phosphate in peripheral blood of patients with idiopathic pulmonary fibrosis[J].J Med Investigat,2022,69(3.4):196-203.
|
10 |
American Thoracic Society; European Respiratory Society.American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society(ERS) was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001 [J].Am J Respir Crit Care Med,2002,165(2):277-304.
|
11 |
孙英梅,闫慧明.血清MMP-7、ADAM17 在结缔组织病相关间质性肺病中的表达及相关性研究[J].风湿病与关节炎,2024,13(5):20-26.
|
12 |
Singh N,Dorfmüller P,Shlobin OA,et al.Group 3 pulmonary hypertension:from bench to bedside[J].Circ Res,2022,130(9):1404-1422.
|
13 |
Beghé B,Cerri S,Fabbri LM,et al.COPD,pulmonary fibrosis and ILAs in aging smokers:the paradox of striking different responses to the major risk factors[J].Int J Mol Sci,2021,22(17):9292.
|
14 |
Sweis JJG,Sweis NWG,Alnaimat F,et al.Immune-mediated lung diseases:A narrative review[J].Front Med (Lausanne),2023,10:1160755.
|
15 |
Atzeni F,Alciati A,Gozza F,et al.Interstitial lung disease in rheumatic diseases:an update of the 2018 review [J].Expert Rev Clin Immunol,2024:1-18.
|
16 |
Li J,Huang Y,Zhang Y,et al.S1P/S1PR signaling pathway advancements in autoimmune diseases[J].Biomol Biomed,2023,23(6):922.
|
17 |
Verstockt B,Vetrano S,Salas A,et al.Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease[J].Nat Rev Gastroenterol Hepatol,2022,19(6):351-366.
|
18 |
Alqalyoobi S,Adegunsoye A,Linderholm A,et al.Circulating plasma biomarkers of progressive interstitial lung disease[J].Am J Respir Crit Care Med,2020,201:250-253.
|
19 |
Lewis KL,Helgeson SA,Tatari MM,et al.COVID-19 and the effects on pulmonary function following infection:a retrospective analysis[J].E Clin Med,2021,39:101079.
|
20 |
Huang LS,Berdyshev EV,Tran JT,et al.Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis:role of S1P signalling and autophagy[J].Thorax,2015,70:1138-1148.
|
21 |
王梦琰,崔 培,辛海明.1-磷酸鞘氨醇在急性肺损伤中的作用研究进展[J].中华烧伤与创面修复杂志,2022,38(5):496-500.
|
22 |
Donati C,Cencetti F,Bernacchioni C,et al.Role of sphingosine 1-phosphate signalling in tissue fibrosis[J].Cell Signal,2021,78:109861.
|
23 |
Fan X,Liu L,Shi Y,et al.Recent advances of the function of sphingosine 1-phosphate (S1P) receptor S1P3[J].J Cell Physiol,2021,236(3):1564-1578.
|
24 |
Terlizzi M,Colarusso C,Somma P,et al.S1P-Induced TNF-α and IL-6 release from PBMCs exacerbates lung cancer-associated inflammation[J].Cells,2022,11(16):2524-2535.
|
25 |
Qin HY,Li MD,Xie GF,et al.Associations among S100A4,sphingosine-1-phosphate,and pulmonary function in patients with chronic obstructive pulmonary disease [J].Oxidat Med Cellul Longevity,2022,2022(1):6041471-6041479.
|
26 |
Suryadevara V,Ramchandran R,Kamp DW,et al.Lipid mediators regulate pulmonary fibrosis:potential mechanisms and signaling pathways[J].Int J Mol Sci,2020,21(12):4257.
|
27 |
Jayant G,Kuperberg S,Somnay K,et al.The role of sphingolipids in regulating vascular permeability in idiopathic pulmonary fibrosis[J].Biomedicines,2023,11(6):1728-1742.
|
28 |
Huang LS,Sudhadevi T,Fu P,et al.Sphingosine Kinase 1/S1P signaling contributes to pulmonary fibrosis by activating Hippo/YAP Pathway and mitochondrial reactive oxygen species in lung fibroblasts[J].Int J Mol Sci,2020,21(6):2064-2085.
|
29 |
Cartier A,Hla T.Sphingosine 1-phosphate:Lipid signaling in pathology and therapy[J].Science,2019,366(6463):eaar5551.
|
30 |
Ouyang J,Shu Z,Chen S,et al.The role of sphingosine 1-phosphate and its receptors in cardiovascular diseases[J].J Cell Mol Med,2020,24(18):10290-10301.
|